[Therapeutic plans for the treatment of HPV infections by systemic administration of interferon-alpha. Experience with preneoplastic pathology of the uterine cervix associated with viral cytopathic effects].
The principal action of IFN is anti-viral, rather than antiproliferative and immunomodulatory. All three actions are required to resolve pre-neoplastic uterine cervix pathologies, above all if they are at an early stage or associated with viral cytopathic effects.
Zarcone
R
R
Istituto di Ginecologia e Ostetricia, II Facoltà di Medicina e Chirurgia, Università degli Studi di Napoli.
Cardone
G
G
Addonizio
D
D
Cardone
A
A
D000276:Adjuvants, Immunologic; D000328:Adult; D000553:Ambulatory Care; D003588:Cytopathogenic Effect, Viral; D005260:Female; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage* / Q000627:therapeutic use; D011230:Precancerous Conditions / Q000188:drug therapy* / Q000276:immunology; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology
D000276:Adjuvants, Immunologic; D016898:Interferon-alpha
Schemi terapeutici per il trattamento delle infezioni da HPV mediante l'uso di interferon alfa per via sistemica. Nostra esperienza nella patologia pre-neoplastica della cervice uterina associata a effetti citopatici da virus.